Percutaneous Coronary Intervention versus Optimal Medical Therapy in Patients with Chronic Total Occlusion: A

Sascha Macherey-Meyer1, Khalid Salem2, Sebastian Heyne1

  • 1Clinic III for Internal Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, Kerpener Straße 62, 50937 Cologne, Germany.

PubMed

Insights

Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) significantly reduces adverse cardiac events compared to optimal medical therapy (OMT). This meta-analysis confirms PCI

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Chronic total occlusion (CTO) is common in coronary artery disease, linked to higher mortality.
  • Previous studies on percutaneous coronary intervention (PCI) versus optimal medical therapy (OMT) for CTO yielded controversial results.
  • Emerging evidence necessitates a comprehensive meta-analysis to clarify treatment efficacy.

Purpose of the Study:

  • To evaluate the effectiveness of PCI compared to OMT in managing CTO.
  • To synthesize data from recent studies to provide updated insights into CTO treatment outcomes.

Main Methods:

  • A systematic literature search identified relevant randomized controlled trials (RCTs) and non-randomized studies.
  • The primary endpoint was a composite of cardiac mortality, myocardial infarction, and target vessel revascularization.
  • Data from 32 studies involving 11,260 patients were analyzed.

Main Results:

  • PCI was associated with a significant reduction in the primary composite outcome (OR 0.66; 95% CI 0.50-0.88; p=0.005).
  • This benefit was consistent across study designs, including RCTs (OR 0.58; 95% CI 0.33-0.99; p=0.05).
  • The observed advantages were primarily driven by target vessel revascularization, though mortality and myocardial infarction also showed significant reductions.

Conclusions:

  • PCI for CTO improves patient-oriented outcomes compared to OMT.
  • The findings suggest a significant reduction in mortality and myocardial infarction, irrespective of study design.
  • Further large-scale RCTs are needed to confirm these hypothesis-generating results.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655